208 related articles for article (PubMed ID: 30545440)
1. SETDB1 regulates SMAD7 expression for breast cancer metastasis.
Ryu TY; Kim K; Kim SK; Oh JH; Min JK; Jung CR; Son MY; Kim DS; Cho HS
BMB Rep; 2019 Feb; 52(2):139-144. PubMed ID: 30545440
[TBL] [Abstract][Full Text] [Related]
2. Histone methyltransferase SETDB1 promotes cells proliferation and migration by interacting withTiam1 in hepatocellular carcinoma.
Zhang Y; Huang J; Li Q; Chen K; Liang Y; Zhan Z; Ye F; Ni W; Chen L; Ding Y
BMC Cancer; 2018 May; 18(1):539. PubMed ID: 29739365
[TBL] [Abstract][Full Text] [Related]
3. Smad3-mediated recruitment of the methyltransferase SETDB1/ESET controls
Du D; Katsuno Y; Meyer D; Budi EH; Chen SH; Koeppen H; Wang H; Akhurst RJ; Derynck R
EMBO Rep; 2018 Jan; 19(1):135-155. PubMed ID: 29233829
[TBL] [Abstract][Full Text] [Related]
4. SETDB1 induces epithelial‑mesenchymal transition in breast carcinoma by directly binding with Snail promoter.
Yang W; Su Y; Hou C; Chen L; Zhou D; Ren K; Zhou Z; Zhang R; Liu X
Oncol Rep; 2019 Feb; 41(2):1284-1292. PubMed ID: 30483750
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of SETDB1 inhibits breast cancer progression by miR-381-3p-related regulation.
Wu M; Fan B; Guo Q; Li Y; Chen R; Lv N; Diao Y; Luo Y
Biol Res; 2018 Oct; 51(1):39. PubMed ID: 30309377
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
Wong CM; Wei L; Law CT; Ho DW; Tsang FH; Au SL; Sze KM; Lee JM; Wong CC; Ng IO
Hepatology; 2016 Feb; 63(2):474-87. PubMed ID: 26481868
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic localization of SETDB1‑induced Warburg effect via c‑MYC‑LDHA axis enhances migration and invasion in breast carcinoma.
Yang W; Wei Y; Wang T; Xu Y; Jin X; Qian H; Yang S; He S
Int J Mol Med; 2024 Apr; 53(4):. PubMed ID: 38426579
[TBL] [Abstract][Full Text] [Related]
8. High SET Domain Bifurcated 1 (SETDB1) Expression Predicts Poor Prognosis in Breast Carcinoma.
Zhou Z; Wu B; Tang X; Yang W; Zou Q; Wang H
Med Sci Monit; 2020 Apr; 26():e922982. PubMed ID: 32305991
[TBL] [Abstract][Full Text] [Related]
9. Setdb1, a novel interactor of ΔNp63, is involved in breast tumorigenesis.
Regina C; Compagnone M; Peschiaroli A; Lena A; Annicchiarico-Petruzzelli M; Piro MC; Melino G; Candi E
Oncotarget; 2016 May; 7(20):28836-48. PubMed ID: 26840455
[TBL] [Abstract][Full Text] [Related]
10. The c-MYC-BMI1 axis is essential for SETDB1-mediated breast tumourigenesis.
Xiao JF; Sun QY; Ding LW; Chien W; Liu XY; Mayakonda A; Jiang YY; Loh XY; Ran XB; Doan NB; Castor B; Chia D; Said JW; Tan KT; Yang H; Fu XY; Lin DC; Koeffler HP
J Pathol; 2018 Sep; 246(1):89-102. PubMed ID: 29926931
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of SETDB1 possesses prognostic value and promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma.
Huang J; Huang W; Liu M; Zhu J; Jiang D; Xiong Y; Zhen Y; Yang D; Chen Z; Peng L; Yu Z
Oncol Rep; 2018 Aug; 40(2):1017-1025. PubMed ID: 29901162
[TBL] [Abstract][Full Text] [Related]
12. A regulatory circuitry comprising TP53,
Chen B; Wang J; Wang J; Wang H; Gu X; Tang L; Feng X
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054425
[TBL] [Abstract][Full Text] [Related]
13. The novel prognostic marker, EHMT2, is involved in cell proliferation via HSPD1 regulation in breast cancer.
Kim SK; Kim K; Ryu JW; Ryu TY; Lim JH; Oh JH; Min JK; Jung CR; Hamamoto R; Son MY; Kim DS; Cho HS
Int J Oncol; 2019 Jan; 54(1):65-76. PubMed ID: 30365075
[TBL] [Abstract][Full Text] [Related]
14. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.
Azuma H; Ehata S; Miyazaki H; Watabe T; Maruyama O; Imamura T; Sakamoto T; Kiyama S; Kiyama Y; Ubai T; Inamoto T; Takahara S; Itoh Y; Otsuki Y; Katsuoka Y; Miyazono K; Horie S
J Natl Cancer Inst; 2005 Dec; 97(23):1734-46. PubMed ID: 16333029
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitination of Lysine 867 of the Human SETDB1 Protein Upregulates Its Histone H3 Lysine 9 (H3K9) Methyltransferase Activity.
Ishimoto K; Kawamata N; Uchihara Y; Okubo M; Fujimoto R; Gotoh E; Kakinouchi K; Mizohata E; Hino N; Okada Y; Mochizuki Y; Tanaka T; Hamakubo T; Sakai J; Kodama T; Inoue T; Tachibana K; Doi T
PLoS One; 2016; 11(10):e0165766. PubMed ID: 27798683
[TBL] [Abstract][Full Text] [Related]
16. EHMT2 is a metastasis regulator in breast cancer.
Kim K; Son MY; Jung CR; Kim DS; Cho HS
Biochem Biophys Res Commun; 2018 Feb; 496(2):758-762. PubMed ID: 29337058
[TBL] [Abstract][Full Text] [Related]
17. microRNA-497 Modulates Breast Cancer Cell Proliferation, Invasion, and Survival by Targeting SMAD7.
Liu J; Zhou Y; Shi Z; Hu Y; Meng T; Zhang X; Zhang S; Zhang J
DNA Cell Biol; 2016 Sep; 35(9):521-9. PubMed ID: 27303812
[TBL] [Abstract][Full Text] [Related]
18. Activation of Canonical BMP4-SMAD7 Signaling Suppresses Breast Cancer Metastasis.
Eckhardt BL; Cao Y; Redfern AD; Chi LH; Burrows AD; Roslan S; Sloan EK; Parker BS; Loi S; Ueno NT; Lau PKH; Latham B; Anderson RL
Cancer Res; 2020 Mar; 80(6):1304-1315. PubMed ID: 31941699
[TBL] [Abstract][Full Text] [Related]
19. Lysines 207 and 325 methylation of WDR5 catalyzed by SETD6 promotes breast cancer cell proliferation and migration.
Yao R; Wang Y; Han D; Ma Y; Ma M; Zhao Y; Tan J; Lu J; Xu G; Li X
Oncol Rep; 2018 Nov; 40(5):3069-3077. PubMed ID: 30226578
[TBL] [Abstract][Full Text] [Related]
20. MTA1-mediated transcriptional repression of SMAD7 in breast cancer cell lines.
Salot S; Gude R
Eur J Cancer; 2013 Jan; 49(2):492-9. PubMed ID: 22841502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
